Merck Life Science A/S: Financial statements 2018
CVR: 20830131
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 26,897,123 and a net result of DKK 16,709,359 compared with DKK 8,644,278 the year before. That is an increase of 26.1% compared with the year before. Equity in the 2018 report amounted to DKK 67,061,116. The solvency ratio was 76.8%. The company had 14 employees in the financial year.
- Gross Profit
- DKK 26,897,123
- Profit/Loss
- DKK 16,709,359
- Equity
- DKK 67,061,116
- Total Assets
- DKK 87,348,482
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 26.9M | 16.7M | 67.1M | 14 |
| 2017 | - | 21.3M | 8.6M | 50.4M | 16 |
| 2016 | - | 20.3M | 6.2M | 41.7M | 17 |
| 2015 | - | 34.3M | 7.4M | 35.5M | 17 |
| 2014 | - | 27.5M | 3.9M | 28.1M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of December 3, 2018, Jeanette Sandholmen has joined the board of directors of Merck Life Science A/S.
As of December 3, 2018, Renée Christine Tunold has joined the board of directors of Merck Life Science A/S.
As of December 3, 2018, Hans Christopher Elers Koch has left the board of directors of Merck Life Science A/S.
As of November 15, 2018, Tiina Marjatta Puhakka is registered as adm. dir. of Merck Life Science A/S.
As of November 15, 2018, Hans Christopher Elers Koch has stepped down as adm. dir. of Merck Life Science A/S.
As of September 14, 2018, Hans Christopher Elers Koch has joined the board of directors of Merck Life Science A/S.
As of September 14, 2018, Lars Ohrberg has left the board of directors of Merck Life Science A/S.
As of September 14, 2018, Hans Christopher Elers Koch is registered as adm. dir. of Merck Life Science A/S.
As of September 14, 2018, Lars Ohrberg has stepped down as adm. dir. of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2017. Gross profit came to DKK 21,328,958, and the net result was DKK 8,644,278.
About Merck Life Science A/S
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.